Taylor Andrew Lawrence (CIK 1723889) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-12). Recent activity: Sell OBIO (36,352 shares), Sell OBIO (3,076 shares), Buy OBIO (181,000 shares), Sell OBIO (3,452 shares), Sell OBIO (8,670 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Orchestra BioMed Holdings, Inc. (OBIO) | Chief Financial Officer | Sell | 36,352 | $146,135 |
| 2026-05-29 | Orchestra BioMed Holdings, Inc. (OBIO) | Chief Financial Officer | Sell | 3,076 | $12,242 |
| 2026-02-13 | Orchestra BioMed Holdings, Inc. (OBIO) | Chief Financial Officer | Buy | 181,000 | $0 |
| 2026-01-02 | Orchestra BioMed Holdings, Inc. (OBIO) | Chief Financial Officer | Sell | 3,452 | $14,878 |
| 2025-12-12 | Orchestra BioMed Holdings, Inc. (OBIO) | Chief Financial Officer | Sell | 8,670 | $40,489 |
| 2025-11-26 | Orchestra BioMed Holdings, Inc. (OBIO) | Chief Financial Officer | Sell | 3,071 | $16,430 |
| 2025-09-19 | Orchestra BioMed Holdings, Inc. (OBIO) | Chief Financial Officer | Sell | 16,102 | $39,611 |
| 2025-08-25 | Orchestra BioMed Holdings, Inc. (OBIO) | Chief Financial Officer | Buy | 2,000 | $5,100 |
| 2025-08-08 | Orchestra BioMed Holdings, Inc. (OBIO) | Chief Financial Officer | Buy | 80,000 | $0 |
| 2025-06-13 | Orchestra BioMed Holdings, Inc. (OBIO) | Chief Financial Officer | Sell | 28,172 | $88,460 |
| 2025-04-04 | Orchestra BioMed Holdings, Inc. (OBIO) | Chief Financial Officer | Buy | 84,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-12